The role of HIF-1α in chemo-/radioresistant tumors

Y Xia, L Jiang, T Zhong - OncoTargets and therapy, 2018 - Taylor & Francis
Chemo-/radioresistance is a major obstacle in clinical oncology. The precise failure
mechanisms of chemo-/radioresistance are multifactorial failures. It is now widely accepted …
被引用次数：80 相关文章

The role of HIF-1α in chemo-/radioresistant tumors.

Y Xia, L Jiang, T Zhong - OncoTargets & Therapy, 2018 - search.ebscohost.com
Chemo-/radioresistance is a major obstacle in clinical oncology. The precise failure
mechanisms of chemo-/radioresistance are multifactorial failures. It is now widely accepted …

The role of HIF-1α in chemo-/radioresistant tumors

X Yu, L Jiang, T Zhong - OncoTargets and Therapy, 2018 - search.proquest.com
Chemo-/radioresistance is a major obstacle in clinical oncology. The precise failure
mechanisms of chemo-/radioresistance are multifactorial failures. It is now widely accepted …

The role of HIF-1 [alpha] in chemo-/radioresistant tumors

Y Xia, L Jiang, T Zhong - OncoTargets and Therapy, 2018 - go.gale.com
Chemo-/radioresistance is a major obstacle in clinical oncology. The precise failure
mechanisms of chemo-/radioresistance are multifactorial failures. It is now widely accepted …

The role of HIF-1α in chemo-/radioresistant tumors

Y Xia, L Jiang, T Zhong - OncoTargets and Therapy, 2018 - dovepress.com
Chemo-/radioresistance is a major obstacle in clinical oncology. The precise failure
mechanisms of chemo-/radioresistance are multifactorial failures. It is now widely accepted …
[HTML] nih.gov

[HTML][HTML] The role of HIF-1α in chemo-/radioresistant tumors

Y Xia, L Jiang, T Zhong - OncoTargets and therapy, 2018 - ncbi.nlm.nih.gov
Chemo-/radioresistance is a major obstacle in clinical oncology. The precise failure
mechanisms of chemo-/radioresistance are multifactorial failures. It is now widely accepted …

The role of HIF-1α in chemo-/radioresistant tumors

Y Xia, L Jiang, T Zhong - OncoTargets and therapy, 2018 - pubmed.ncbi.nlm.nih.gov
Chemo-/radioresistance is a major obstacle in clinical oncology. The precise failure
mechanisms of chemo-/radioresistance are multifactorial failures. It is now widely accepted …

The role of HIF-1α in chemo-/radioresistant tumors.

Y Xia, L Jiang, T Zhong - Oncotargets and Therapy, 2018 - europepmc.org
Chemo-/radioresistance is a major obstacle in clinical oncology. The precise failure
mechanisms of chemo-/radioresistance are multifactorial failures. It is now widely accepted …
[PDF] scienceopen.com

[PDF][PDF] The role of HiF-1α in chemo-/radioresistant tumors

Y Xia - OncoTargets and Therapy, 2018 - scienceopen.com
Chemo-/radioresistance is a major obstacle in clinical oncology. The precise failure
mechanisms of chemo-/radioresistance are multifactorial failures. It is now widely accepted …

[引用][C] The role of HIF-1α in chemo-/radioresistant tumors

Y Xia, L Jiang, T Zhong - OncoTargets and Therapy, 2018 - cir.nii.ac.jp
The role of HIF-1α in chemo-/radioresistant tumors | CiNii Research CiNii 国立情報学
研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学 …